About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in California | 1,207 Studies

Clinical Trials Prostate CancerCalifornia

Prostate Cancer Clinical Trials in California

Find 1,207 clinical trials for prostate cancer near California. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in California

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 701-720 of 1,207 trials

CompletedIn-Situ Therapeutic Cancer Vaccine for Metastatic Cancer Combining AlloStim With Tumor CryoablationThis is a Phase I/II study to investigate the feasibility of creating a personalized therapeutic cancer vaccine within the body.NCT00861107·Carlsbad, California TerminatedNordihydroguaiaretic Acid in Treating Patients With Nonmetastatic Relapsed Prostate CancerRATIONALE: Nordihydroguaiaretic acid may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.NCT00313534·San Francisco, California Active not recruitingA Study of an Intermittent ADT Approach With Apalutamide Monotherapy in Participants With mCSPCThe purpose of the study is to determine if the intermittent use of androgen-deprivation therapy (ADT) in participants with metastatic castrate-sensitive prostate cancer (mCSPC)…NCT05884398·Homewood, Alabama and 92 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedZoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone TherapyRATIONALE: Zoledronate may prevent bone loss in patients with prostate cancer undergoing radiation therapy and hormone therapy.NCT00329797·Chico, California and 87 others

WithdrawnA Study of Tazemetostat (Tazverik) Before Prostatectomy in Men With Prostate CancerThis study is an open-label, single-arm, pilot, perioperative study of EZH2 inhibition in patients undergoing Radical Prostatectomy (RP).NCT05567679·Los Angeles, California

RecruitingHigh Cardiovascular Risk Intervention With Cardio-Oncology Consultation for Prostate Cancer Following Androgen Receptor Pathway Inhibitor (ARPI) Therapy (Heart-Safe)In patients with prostate cancer (PC), cardiovascular disease (CVD) causes significant morbidity and is the second leading cause of death.NCT07223385·Los Angeles, California

CompletedStudy of the Safety, Tolerability and Efficacy of KPT-8602 in Participants With Relapsed/Refractory Cancer IndicationsThis is a first-in-human, multi-center, open-label clinical study with separate dose escalation (Phase 1) and expansion (Phase 2) stages to assess preliminary safety…NCT02649790·Los Angeles, California and 45 others

RecruitingA Study of MT-4561 in Patients With Various Advanced Solid TumorsThis is a First In Human (FIH), multicenter, open-label, Phase I/II study to evaluate safety, tolerability, Pharmacokinetics (PK), pharmacodynamics, and efficacy of MT-4561 in…NCT06943521·Los Angeles, California and 5 others

CompletedThe BurnAlong Pilot Study for Adolescent and Young Adult Cancer SurvivorsThe purpose of this prospective, interventional, single-arm pilot study is to evaluate whether virtually delivered group-based physical activity is feasible for adolescent and…NCT05131815·Los Angeles, California

CompletedA Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid TumorsPhase 1/2 study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of SNS-101, a novel anti VISTA IgG1 monoclonal antibody as monotherapy or in…NCT05864144·Los Angeles, California and 9 others

Active not recruitingTRUEBEAM Stereotactic Body Radiotherapy for Localized Prostate CancerThe purpose of this study is to determine the effects of TrueBeam stereotactic body radiosurgery in patients with prostate cancer.NCT04552509·Laguna Hills, California

TerminatedA Study of Ixabepilone Before Surgery for High-Risk Localized Prostate CancerThe purpose of this research study is to determine the safety and effectiveness of the investigational drug, Ixabepilone, in men with high risk prostate cancer who plan to receive…NCT00672009·Los Angeles, California

TerminatedStudy of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)The purpose of this study is to assess the efficacy and safety of the combination of pembrolizumab (MK-3475) and enzalutamide in the treatment of men with metastatic…NCT03834493·Mobile, Alabama and 258 others

CompletedSystemic and Tumor-Directed Therapy for Oligometastatic Prostate CancerThis is a trial for patients with newly diagnosed metastatic prostate cancer with 5 or fewer sites of metastases.NCT03298087·Long Beach, California and 2 others

CompletedMagnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Diagnosing the Extent of Disease in Patients With Prostate CancerRATIONALE: Imaging procedures such as magnetic resonance imaging (MRI) and magnetic resonance spectroscopic imaging (MRSI) may improve the ability to detect the extent of prostate…NCT00032058·San Francisco, California and 7 others

TerminatedMolecular Characterization of CTCs and ctDNA in Blood and Plasma Samples From Patients With Metastatic and/or Hormone-Resistant Prostate CancerThis research trial studies molecular characterization of circulating tumor cells (CTCs) and circulating tumor (ct) deoxyribonucleic acid (DNA) in blood and plasma samples from…NCT02370355·Los Angeles, California

CompletedAdjuvant Taxotere in Patients With High Risk Prostate Cancer Post Prostatectomy and RadiationThe purpose of this study is to evaluate time to progression (TTP) by PSA in patients with high risk prostate cancer after definitive therapy.NCT00186420·Stanford, California

Active not recruitingWATER IV Prostate CancerThis is a multicenter, prospective, randomized clinical trial that aims to assess the safety and efficacy of Aquablation Therapy in men with low-risk to intermediate to high-risk…NCT06651632·Chandler, Arizona and 36 others

UnknownCyberKnife Radiosurgery for Localized Prostatic CarcinomaVirtual high dose rate (HDR) CyberKnife (CK) prostate treatment has comparable morbidity and efficacy compared with actual prostate HDR treatment, but does it without the…NCT01045148·San Diego, California

CompletedPhotoacoustic Imaging (PAI) of the Prostate: A Clinical Feasibility StudyThe purpose of our study is to image human prostate tissue using a transrectal photoacoustic imaging probe.NCT01551576·Stanford, California

PreviousPage 36 of 61Next

Other Conditions in California

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma